Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Rolando Ulloa-Gutierrez, Greta Miño, Carla Odio, María L Avila-Aguero & José Brea. (2011) Vaccine-preventable diseases and their impact on Latin American children. Expert Review of Vaccines 10:12, pages 1671-1673.
Read now
Read now
Articles from other publishers (12)
Ana Morice, Leandra Abarca-Gómez, Roberto Arroba, María Luisa Avila-Agüero, Daniel Salas-Peraza, Stephanie Shendale & Shalini Desai. (2023) Health workers vaccination: Experience and lessons learned from Costa Rica. Vaccine: X 15, pages 100376.
Crossref
Crossref
Ali Al-kassab-Córdova, Omar Napanga-Saldaña, Ricardo Peña-Sánchez, Alfonso J. Rodríguez-Morales & Edward Mezones-Holguín. (2023) Vaccine-derived polio in Peru after 32 years of elimination: reflections on the routine childhood immunisation coverages. The Lancet Regional Health - Americas 23, pages 100532.
Crossref
Crossref
N. Dumpa, K. Goel, Yuhan Guo, H. McFall, Amit Raviraj Pillai, Ashay Shukla, M. A. Repka & S. Narasimha Murthy. (2019) Stability of Vaccines. AAPS PharmSciTech 20:2.
Crossref
Crossref
Andrés Lizasoain, Fernanda M. Burlandy, Matías Victoria, Luis F. López Tort, Edson E. da Silva & Rodney Colina. (2018) An Environmental Surveillance in Uruguay Reveals the Presence of Highly Divergent Types of Human Enterovirus Species C and a High Frequency of Species A and B Types. Food and Environmental Virology 10:4, pages 343-352.
Crossref
Crossref
Wei Qi, Scott Orgel, Alain Francon, Theodore W. Randolph & John F. Carpenter. (2018) Urea Improves Stability of Inactivated Polio Vaccine Serotype 3 During Lyophilization and Storage in Dried Formulations. Journal of Pharmaceutical Sciences 107:8, pages 2070-2078.
Crossref
Crossref
Ana Marli Christovam Sartori, Margarete Paganotti Vicentine, Lígia Castelloni Figueiredo Gryninger, Patricia Coelho de Soárez & Hillegonda Maria Dutilh Novaes. (2015) Polio inactivated vaccine costs into routine childhood immunization in Brazil. Revista de Saúde Pública 49:0.
Crossref
Crossref
Jerson L. Silva, Shana P. C. Barroso, Ygara S. Mendes, Carlos H. Dumard, Patricia S. Santos, Andre M. O. Gomes & Andréa C. Oliveira. 2015. High Pressure Bioscience. High Pressure Bioscience
301
318
.
C. M. A. S. Domingues, S. de Fatima Pereira, A. C. Cunha Marreiros, N. Menezes & B. Flannery. (2014) Introduction of Sequential Inactivated Polio Vaccine-Oral Polio Vaccine Schedule for Routine Infant Immunization in Brazil's National Immunization Program. Journal of Infectious Diseases 210:suppl 1, pages S143-S151.
Crossref
Crossref
J. Mauricio Landaverde, Silas Pierson Trumbo, M. Carolina Danovaro-Holliday, Shea E. Cochi, Raghunathan Gandhi & Cuauht?moc Ruiz-Matus. (2014) Vaccine-Associated Paralytic Poliomyelitis in the Postelimination Era in Latin America and the Caribbean, 1992?2011. The Journal of Infectious Diseases 209:9, pages 1393-1402.
Crossref
Crossref
Wei Qi, Yuhong Zeng, Scott Orgel, Alain Francon, Jae Hyun Kim, Theodore W. Randolph, John F. Carpenter & C. Russell Middaugh. (2014) Preformulation Study of Highly Purified Inactivated Polio Vaccine, Serotype 3. Journal of Pharmaceutical Sciences 103:1, pages 140-151.
Crossref
Crossref
Mauricio Rodríguez-Álvarez, María Eugenia Jiménez-Corona, Rocío Cervantes-Rosales & Samuel Ponce de León-Rosales. (2013) Polio Eradication: How Long and How Much to the End?. Archives of Medical Research 44:5, pages 401-404.
Crossref
Crossref
Ahd HamidiWilfried AM Bakker. (2012) Innovative IPV from attenuated Sabin poliovirus or newly designed alternative seed strains. Pharmaceutical Patent Analyst 1:5, pages 589-599.
Crossref
Crossref